West Pharmaceutical Services revenue and financials
$372.64Change from previous close: −1.09%Absolute change: −$4.12
In the fiscal year ended December 2025, West Pharmaceutical Services reported revenue of $3.07B (+6.25% year over year). Net income was $493.7M, a net margin of 16.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.25%
- 2025 vs 2024
- Net income growth
- +0.20%
- 2025 vs 2024
- Net margin
- 16.1%
- 2024: 17.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 124 | 89.9 | 251 | 197 | 177 | 129 | 190 | 180 | 165 | 118 | 239 | 230 |
| Depreciation and amortization | 46.2 | 45.2 | 47.0 | 43.0 | 41.4 | 40.0 | 40.7 | 40.2 | 38.9 | 35.6 | 35.9 | 35.7 |
| Capital expenditure | -43.2 | -42.7 | -76.1 | -63.3 | -75.2 | -71.3 | -105 | -81.3 | -100 | -90.6 | -109 | -95.8 |
| Investing cash flow | -43.2 | -42.7 | -76.1 | -63.3 | -75.2 | -71.3 | -105 | -82.1 | -101 | -90.6 | -109 | -95.7 |
| Financing cash flow | -165 | -309 | -11.7 | -11.5 | -14.9 | -147 | -68.9 | -64.4 | -218 | -271 | -190 | -22.3 |
| Dividends paid | -15.7 | -15.8 | -15.8 | -15.1 | -15.1 | -15.2 | -15.3 | -14.5 | -14.6 | -14.7 | -14.8 | -14.0 |
| Share repurchases | -157 | -300 | -0.2 | -0.1 | -0.5 | -136 | -54.6 | -52.4 | -187 | -272 | -177 | -28.1 |
| Debt issued | 50.0 | — | 0.0 | 0.0 | — | — | — | 130 | 35.0 | — | — | — |
| Debt repaid | -50.4 | -0.3 | -0.3 | -0.3 | -0.3 | -0.2 | -0.1 | -133 | -58.3 | -0.7 | -0.7 | -0.6 |
| Effect of exchange rates | -1.6 | -8.4 | -0.5 | -3.6 | 18.5 | 8.5 | -22.7 | 11.1 | -1.1 | -8.7 | 14.5 | -9.8 |
| Net change in cash | -85.6 | -270 | 163 | 119 | 106 | -80.4 | -6.3 | 44.7 | -156 | -252 | -44.7 | 102 |
| Free cash flow | 80.8 | 47.2 | 175 | 134 | 102 | 58.1 | 85.2 | 98.8 | 64.8 | 27.6 | 130 | 134 |
| Levered free cash flow | 35.6 | 24.4 | 113 | 104 | 34.2 | 22.6 | 89.6 | 61.0 | 59.9 | -4.2 | 82.4 | 31.4 |